Watson Pharma Private Limited, a active private limited company, was established on 21 October 2005 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH2005PTC156968. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹200.00 Cr and a paid-up capital of ₹161.98 Cr.
It upholds a compliant status. Employing 1,125 professional, Its leadership includes Nishank Bhargava (Director), Agnieszka Monika Lubkowska (Director), Chandrasekhar Bhagwan Sinha (Additional Director). Past directors included Dilip Indravadan Joshi, Allen Yuten Chao, Francois Andre Menard. It holds ₹25.00 Cr open charges and ₹8.60 Cr settled loans. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8Th Floor, Tower C, Times Square, Andheri Kurla Road, Gamdevi, Marol, Andh, Eri East, Mumbai, Maharashtra, 400059.
U24230MH2005PTC156968
156968
21 October 2005
₹200.00 Cr
₹161.98 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Watson Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishank Bhargava | Director | 24 Feb 2022 | Current |
| Agnieszka Monika Lubkowska | Director | 26 Jun 2024 | Current |
| Chandrasekhar Bhagwan Sinha | Additional Director | 08 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Nov 2006 | Past |
| Pramod Abcsdd | Director | 27 Jun 2008 | Past |
| Pramod Abcsdd | Additional Director | 22 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 22 Jun 2011 | Past |
| Pramod Abcsdd | Director | 02 Aug 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Watson Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7% increase. The company also saw a slight decrease in profitability, with a 8.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Watson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹250,000,000.00
₹86,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2009 | Hdfc Bank Limited | ₹25.00 Cr | Open |
| 29 Nov 2005 | Standard Chartered Bank | ₹8.00 M | Satisfied |
| 23 Aug 2005 | Standard Chartered Bank | ₹8.00 M | Satisfied |
| 30 Oct 2002 | Bank Of Baroda | ₹3.50 Cr | Satisfied |
| 18 Jan 2002 | Corporation Bank | ₹3.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Watson Pharma has a workforce of 1125 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Watson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Watson Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Watson Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was completed.
The activity Chandrasekhar Bhagwan Sinha was appointed as a Additional Director was appointed as a Additional Director on 08 Aug 2025 & has been associated with this company since 4 months 11 days . was completed.
The activity Watson Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Agnieszka Monika Lubkowska was appointed as a Director was appointed as a Director on 26 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
The activity Nishank Bhargava was appointed as a Director was appointed as a Director on 24 Feb 2022 & has been associated with this company since 3 years 9 months . was completed.
Progress on Vivek Jugal Kishor Saraf was appointed as a Company Secretary was appointed as a Company Secretary on 24 Nov 2016 & has been associated with this company since 9 years 23 days . was documented.
The CIN of Watson Pharma Private Limited is U24230MH2005PTC156968.
Watson Pharma Private Limited is headquartered at 8Th Floor, Tower C, Times Square, Andheri Kurla Road, Gamdevi, Marol, Andh, Eri East, Mumbai, Maharashtra, 400059.
Watson Pharma Private Limited was incorporated on 21 October 2005.
The current directors of Watson Pharma Private Limited are
The primary industry of Watson Pharma Private Limited is Manufacturing.
Watson Pharma Private Limited is unlisted.
The authorized capital of Watson Pharma Private Limited is ₹200.00 Cr, and the paid-up capital is ₹161.98 Cr.
The compliance status of Watson Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX